Cargando…

Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity

Objective: To determine the effects of oxygen fluctuations on pigment epithelial-derived factor (PEDF) and vascular endothelial growth factor (VEGF)/PEDF ratios in a relevant rat model of retinopathy of prematurity (ROP). METHODS: The expression of retinal PEDF mRNA and of VEGF and PEDF protein were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hartmann, John S., Thompson, Hilary, Wang, Haibo, Kanekar, Shami, Huang, Wei, Budd, Steven J., Hartnett, M. Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Vision 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123158/ https://www.ncbi.nlm.nih.gov/pubmed/21738387

Ejemplares similares

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2021)

Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2–induced intravitreal neovascularization in a rat model of retinopathy of prematurity
por: Wang, Haibo, et al.
Publicado: (2014)

Enhancing Retinal Endothelial Glycolysis by Inhibiting UCP2 Promotes Physiologic Retinal Vascular Development in a Model of Retinopathy of Prematurity
por: Han, Xiaokun, et al.
Publicado: (2019)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
por: Gangwe, Anil, et al.
Publicado: (2021)

Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease
por: Angayarkanni, Narayanasamy, et al.
Publicado: (2009)

Ratio of the vitreous vascular endothelial growth factor and pigment epithelial-derived factor in Eales disease
por: Angayarkanni, Narayanasamy, et al.
Publicado: (2009)

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
por: Velez-Montoya, Raul, et al.
Publicado: (2010)

Role of Serum Levels of Vascular Endothelial Growth Factor and Its Receptor in Retinopathy of Prematurity
por: Goswami, Binita, et al.
Publicado: (2015)

Anti-vascular endothelial growth factor therapy in retinopathy of prematurity: An updated literature review
por: Alzuabi, Asma K., et al.
Publicado: (2022)

Progression of retinal vascularization after intravitreal anti-vascular-endothelial growth factor therapy in retinopathy of prematurity
por: Mirghorbani, Masoud, et al.
Publicado: (2022)

The Effects of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Erythropoietin, and Their Interactions in Angiogenesis: Implications in Retinopathy of Prematurity
por: Cung, Thaonhi, et al.
Publicado: (2022)

Current Concepts of Oxygen Management in Retinopathy of Prematurity
por: Owen, Leah A., et al.
Publicado: (2014)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
por: Dudani, Ajay Indur, et al.
Publicado: (2019)

Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes
por: Kang, Hyun Goo, et al.
Publicado: (2018)

Advances in diagnosis, clinical care, research, and treatment in retinopathy of prematurity
por: Hartnett, M Elizabeth, et al.
Publicado: (2016)

RNA-Seq Provides Insights into VEGF-Induced Signaling in Human Retinal Microvascular Endothelial Cells: Implications in Retinopathy of Prematurity
por: Ramshekar, Aniket, et al.
Publicado: (2022)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
por: Chen, Xuting, et al.
Publicado: (2019)

Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity
por: Dogra, Mohit, et al.
Publicado: (2021)

Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity
por: Sindal, Manavi D, et al.
Publicado: (2021)

Discovering Mechanisms in the Changing and Diverse Pathology of Retinopathy of Prematurity: The Weisenfeld Award Lecture
por: Hartnett, M. Elizabeth
Publicado: (2019)

Speed of Retinal Vascularization in Retinopathy of Prematurity: Risk and Protective Factors
por: Solans Pérez de Larraya, Ana Maria, et al.
Publicado: (2019)

Diabetic retinopathy and vascular endothelial growth factor
por: Khazaei, Majid
Publicado: (2013)

Effect of glycemic control and dyslipidemia on plasma vascular endothelial growth factor and pigment epithelium-derived factor in diabetic retinopathy patients in Northern Nigeria
por: Unung, Paulinus Jimmy, et al.
Publicado: (2020)

Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
por: Kondo, Chiori, et al.
Publicado: (2022)

Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
por: Taher, Nada O., et al.
Publicado: (2022)

The Effects of Anti-Vascular Endothelial Growth Factor Drugs on Retinal Pigment Epithelial Cell Culture
por: Şahiner, Mustafa, et al.
Publicado: (2018)

Can a Risk Factor Based Approach Safely Reduce Screening for Retinopathy of Prematurity?
por: Friddle, K. M., et al.
Publicado: (2017)

Laser versus Anti-VEGF: A Paradigm Shift for Treatment-Warranted Retinopathy of Prematurity
por: Hartnett, M. Elizabeth, et al.
Publicado: (2023)

Protective effect of maternal uteroplacental insufficiency on oxygen-induced retinopathy in offspring: removing bias of premature birth
por: Becker, Silke, et al.
Publicado: (2017)

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity
por: Pertl, Laura, et al.
Publicado: (2015)

Safety and efficacy of intravitreal anti vascular endothelial growth factor for severe posterior retinopathy of prematurity with flat fibrovascular proliferation
por: Maitra, Puja, et al.
Publicado: (2023)

Correlation between tear levels of vascular endothelial growth factor and vitamin D at retinopathy of prematurity stages in preterm infants
por: Murugeswari, Ponnalagu, et al.
Publicado: (2023)

Risk Factors for Retinopathy of Prematurity in Premature Born Children
por: Alajbegovic-Halimic, Jasmina, et al.
Publicado: (2015)

Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity
por: Geisen, P., et al.
Publicado: (2008)

Retinopathy of prematurity protection conferred by uteroplacental insufficiency through erythropoietin signaling in an experimental Murine Model
por: Fung, Camille, et al.
Publicado: (2023)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF(165)b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
por: Zhao, Min, et al.
Publicado: (2015)

Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
por: Vinekar, Anand
Publicado: (2021)

Retinopathy of prematurity: Metabolic risk factors
por: Fu, Zhongjie, et al.
Publicado: (2022)

Effect of adiponectin on expression of vascular endothelial growth factor and pigment epithelium-derived factor: An in vitro study
por: Srinivasan, Vidhya, et al.
Publicado: (2015)

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)
por: Li, Zijing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5udkb3sqjaknkue9aedbgcklid